aod9604 development discontinued AOD 9604: Peptide Claims vs Clinical Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's side effects. The clinical question tested materials for laboratory and scientific research applications. AOD-9604
Description
Ensure peptides are pure
Like GLP-1 receptor agonists, this medication also works by sending satiety signals to your brain to reduce appetite and delay gastric emptying
Dosing protocols (100-300mcg/day), cycling, and CJC-1295 comparison
These products are not for human consumption, veterinary use, or any other application involving living organisms, including but not limited to diagnostic, therapeutic, or recreational purposes
Lessons for Peptide Drug Development AOD-9604 highlights how promising biochemical logic can falter in translation from bench to bedside
